177 related articles for article (PubMed ID: 37874524)
21. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
Guo LN; Xiao M; Cao B; Qu F; Zhan YL; Hu YJ; Wang XR; Liang GW; Gu HT; Qi J; Yuan H; Min R; Wang FY; Liu LJ; Wang HB; Jiang W; Duan XG; Xu WJ; Yu YH; Su JR; Zhang JZ; Nong JQ; Liu SM; Li J; Liu JT; Yue ZG; Yang D; Guo J; Zhao R; Zhang YN; Yang XM; Liu XQ; Hsueh PR; Xu YC
Future Microbiol; 2017 Sep; 12():1075-1086. PubMed ID: 28836465
[TBL] [Abstract][Full Text] [Related]
22. Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples.
Nourrisson C; Moniot M; Lavergne RA; Robert E; Bonnin V; Hagen F; Grenouillet F; Cafarchia C; Butler G; Cassaing S; Sabou M; Le Pape P; Poirier P; Morio F
Clin Microbiol Infect; 2023 Feb; 29(2):257.e7-257.e11. PubMed ID: 36209989
[TBL] [Abstract][Full Text] [Related]
23. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Wang H; Xiao M; Chen SC; Kong F; Sun ZY; Liao K; Lu J; Shao HF; Yan Y; Fan H; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Xu YC
J Clin Microbiol; 2012 Dec; 50(12):3952-9. PubMed ID: 23035204
[TBL] [Abstract][Full Text] [Related]
24. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
[TBL] [Abstract][Full Text] [Related]
25. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
26. Killer activity of yeasts isolated from natural environments against some medically important Candida species.
Vadkertiová R; Sláviková E
Pol J Microbiol; 2007; 56(1):39-43. PubMed ID: 17419188
[TBL] [Abstract][Full Text] [Related]
27. Diversity and antifungal susceptibility of yeasts from tropical freshwater environments in Southeastern Brazil.
Medeiros AO; Kohler LM; Hamdan JS; Missagia BS; Barbosa FA; Rosa CA
Water Res; 2008 Aug; 42(14):3921-9. PubMed ID: 18678387
[TBL] [Abstract][Full Text] [Related]
28. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
[TBL] [Abstract][Full Text] [Related]
29. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
30. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
31. Diversity, in-vitro virulence traits and antifungal susceptibility pattern of gastrointestinal yeast flora of healthy poultry, Gallus gallus domesticus.
Subramanya SH; Sharan NK; Baral BP; Hamal D; Nayak N; Prakash PY; Sathian B; Bairy I; Gokhale S
BMC Microbiol; 2017 May; 17(1):113. PubMed ID: 28506251
[TBL] [Abstract][Full Text] [Related]
32. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.
González GM; Elizondo M; Ayala J
J Clin Microbiol; 2008 Sep; 46(9):2902-5. PubMed ID: 18632907
[TBL] [Abstract][Full Text] [Related]
33. Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.
Negri M; Martins M; Henriques M; Svidzinski TI; Azeredo J; Oliveira R
Mycopathologia; 2010 Mar; 169(3):175-82. PubMed ID: 19851885
[TBL] [Abstract][Full Text] [Related]
34. Virulence and in vitro antifungal susceptibility of Candida albicans and Candida catenulata from laying hens.
Rhimi W; Aneke CI; Annoscia G; Camarda A; Mosca A; Cantacessi C; Otranto D; Cafarchia C
Int Microbiol; 2021 Jan; 24(1):57-63. PubMed ID: 32772220
[TBL] [Abstract][Full Text] [Related]
35. Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).
Desnos-Ollivier M; Bretagne S; Boullié A; Gautier C; Dromer F; Lortholary O;
Clin Microbiol Infect; 2019 May; 25(5):634.e1-634.e4. PubMed ID: 30771532
[TBL] [Abstract][Full Text] [Related]
36.
Zhang W; Zhan M; Wang N; Fan J; Han X; Li C; Liu J; Li J; Hou Y; Wang X; Zhang Z
J Med Microbiol; 2023 Mar; 72(3):. PubMed ID: 36920840
[No Abstract] [Full Text] [Related]
37. Antifungal activity of 2-chloro-N-phenylacetamide, docking and molecular dynamics studies against clinical isolates of Candida tropicalis and Candida parapsilosis.
Silva SL; de Oliveira Pereira F; Cordeiro LV; Neto HD; Dos Santos Maia M; da Silva Souza HD; de Athayde-Filho PF; Scotti MT; Scotti L; de Oliveira Lima E
J Appl Microbiol; 2022 May; 132(5):3601-3617. PubMed ID: 35179275
[TBL] [Abstract][Full Text] [Related]
38. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and antifungal susceptibility of Candida species in a tertiary care hospital in Islamabad, Pakistan.
Tasneem U; Siddiqui MT; Faryal R; Shah AA
J Pak Med Assoc; 2017 Jul; 67(7):986-991. PubMed ID: 28770873
[TBL] [Abstract][Full Text] [Related]
40. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
